• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Multiple Sclerosis
      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice GBP 140.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        63 210 Ft (60 200 Ft + 5% VAT)
      • Discount 10% (cc. 6 321 Ft off)
      • Discounted price 56 889 Ft (54 180 Ft + 5% VAT)

    63 210 Ft

    db

    Availability

    printed on demand

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher OUP USA
    • Date of Publication 18 July 2013

    • ISBN 9780199740468
    • Binding Hardback
    • No. of pages218 pages
    • Size 185x257x15 mm
    • Weight 828 g
    • Language English
    • 0

    Categories

    Short description:

    This latest edition to the 'Contemporary Neurology Series' will fill one of the few remaining 'neurologic gaps' within the Series. 'Multiple Sclerosis,' written solely by Moses Rodriguez, Orhun Kantarci and Istvan Pirko of the Mayo Clinic in Rochester, MN offers proven, effective treatments for specific presentations and symptoms of multiple sclerosis along with a pathophysiological explanation of why they work.

    More

    Long description:

    This latest edition to the 'Contemporary Neurology Series' will fill one of the few remaining 'neurologic gaps' within the Series. 'Multiple Sclerosis,' written solely by Moses Rodriguez, Orhun Kantarci and Istvan Pirko of the Mayo Clinic in Rochester, MN will offer proven, effective treatments for specific presentations and symptoms of multiple sclerosis along with a pathophysiological explanation of why they work. It bridges a needed gap between overly simplistic therapy manuals and basic science texts that discuss human disease only insofar as it mimics what is observed in animal models of the disease in the laboratory. Additionally, it seeks to offer an efficient integrative approach to symptomatic treatment to avoid over-medication and side effects. It discusses the heterogeneous causes of the disease and the need to develop individualized treatments that address the basic pathophysiologic processes that characterize each patient's disease with the future goal of individualized medicine.

    'Multiple Sclerosis' will covers both the basic research aspects of MS: epidemiology, neuropathology, genetics, and immunology as well as the treatment options associated with the MS patient: sleep, steroids, pharma, neuropsychology, and growth factors (to name a few). 'Multiple Sclerosis' will focus on the medical treatment - drug treatment - of MS rather than on physical medicine and rehabilitation (not the author's strength). The authors will also make ample use of flow diagrams, bulleted points, and tables to help the reader better understand MS and its etiology and treatment.

    More

    Table of Contents:

    SECTION 1 PATHOGENESIS
    1 The Spectrum and Diagnosis of Multiple Sclerosis
    2 The Differential Diagnosis of Multiple Sclerosis
    3 Epidemiology of MS: Genetics and Environment
    4 The Role of Magnetic Resonance Imaging in Multiple Sclerosis
    5 Neuropathology: Clues to Pathogenesis
    6 Immunology: How Much Has Immunology Taught Us About Multiple Sclerosis?
    7 Neural Degeneration and Potential Novel Treatments
    SECTION 2 TREATMENT
    8 Treatment of Multiple Sclerosis: Acute Exacerbations
    9 Disease-modifying Therapies in Multiple Sclerosis
    10 Managing Symptoms of Multiple Sclerosis
    11 Future Disease-modifying Treatment Approaches in MS
    12 Treatment to Promote Remyelination
    Index

    More
    0